Founder Directory
Built by Keitoto
- Serafim Korablev@serafimcloudFounder/CEO · 21stW26B2B · San Francisco
- Sergey Bunas@sergeybunasFounder/CTO · 21stW26B2B · San Francisco
- Lina Colucci@lina_colucciFounder/CEO · LemonSliceW24B2B · San Francisco
- Bruce ChiFounder/CEO · SuretyNowW24Fintech · Austin
- Jay Xiao@yjwxiaoFounder/President · SuretyNowW24Fintech · Austin
- Jack Amadeo@jackamadeoFounder · NeptyneW23B2B · New York
- Brian Wallach@bsw5020Founder · SynapticureS20Healthcare · Chicago
- Martina de Majo@MartinadeMajoFounder · SynapticureS20Healthcare · Chicago
- Peter Wallach@pwallach87Founding CEO, Founder · SynapticureS20Healthcare · Chicago
- Aditya AcharyaFounder · HavenW20Fintech · New York
- Nipun Kant@nipungkantFounder · HavenW20Fintech · New York
- Aaron MorrisFounder · PostEraW20Healthcare · Boston
- Alpha LeeFounder · PostEraW20Healthcare · Boston
- Matthew RobinsonFounder · PostEraW20Healthcare · Boston
- Aidan PorterFounder/CTO · FREYS18Consumer
- Erin Robert FreyFounder/Partner · FREYS18Consumer
- Leif FreyFounder/Head of Direction · FREYS18Consumer
- Chiu ChauFounder · OpentronsW16Healthcare · New York
- Nicholas WagnerFounder · OpentronsW16Healthcare · New York
- Will CanineFounder/CPO · OpentronsW16Healthcare · New York
Showing 1–20 of 22 founders
Martina de Majo
Founder·Synapticure
PRIMARY INFO
BIO
Martina is the director of research and development at Synapticure and she focuses on creating iPSC derived in vitro models to study neurodegenerative disorders. Martina received an undergraduate degree in biotechnology and a Master's degree in pharmaceutical biotechnology from the University of Rome "La Sapienza" (Italy), she then earned a PhD in clinical neuroscience from King's College London (UK) and deepened her knowledge of iPSC derived modelling in her postdoc at UCSF (US)
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
No notable employer or school mentioned in the bio.
TRACK RECORD
COMPANY CONTEXT
We deliver personalized medicine for neurodegenerative patients